Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen D W Beck

Showing results (11-20 of 45) with videos related to

Pageof 5
Sort By:
The Journal of Urology|December 18, 2001
Bilateral testicular epidermoid cysts managed by partial orchiectomyJames C Sloan, Stephen D W Beck, Richard Bihrle, et al.
The Journal of Urology|September 21, 2010
Ejaculatory status and fertility rates after primary retroperitoneal lymph node dissectionStephen D W Beck, Aaron L Bey, Richard Bihrle, et al.
Urology|March 27, 2007
Significance of primary tumor size and preorchiectomy serum tumor marker level in predicting pathologic stage at retroperitoneal lymph node dissection in clinical Stage A nonseminomatous germ cell tumorsStephen D W Beck, Richard S Foster, Richard Bihrle, et al.
The Journal of Urology|September 29, 2012
Clinical and pathological features predictive of nephrectomy at post-chemotherapy retroperitoneal lymph node dissectionK Clint Cary, Stephen D W Beck, Richard Bihrle, et al.
Journal of Pediatric Urology|August 27, 2010
Metastatic transitional cell carcinoma of the bladder arising in a patient with bladder autoaugmentationRahul Mehan, Rosalia Misseri, Brian Vanderbrink, et al.
The Journal of Urology|September 8, 2005
Does the histology of nodal metastasis predict systemic relapse after retroperitoneal lymph node dissection in pathological stage B1 germ cell tumors?Stephen D W Beck, Richard S Foster, Richard Bihrle, et al.
Urologic Oncology|September 9, 2010
Serum tumor markers in testicular cancerYaron Ehrlich, Stephen D W Beck, Richard S Foster, et al.
The Journal of Urology|February 14, 2007
Does the presence of extranodal extension in pathological stage B1 nonseminomatous germ cell tumor necessitate adjuvant chemotherapy?Stephen D W Beck, Liang Cheng, Richard Bihrle, et al.
The Journal of Urology|June 15, 2007
Short-term morbidity of primary retroperitoneal lymph node dissection in a contemporary group of patientsStephen D W Beck, Matthew D Peterson, Richard Bihrle, et al.
The Urologic Clinics of North America|May 9, 2007
Post chemotherapy RPLND in patients with elevated markers: current concepts and clinical outcomeStephen D W Beck, Richard S Foster, Richard Bihrle, et al.
Pageof 5

Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
The Journal of Urology|December 18, 2001
Bilateral testicular epidermoid cysts managed by partial orchiectomyJames C Sloan, Stephen D W Beck, Richard Bihrle, et al.
The Journal of Urology|September 21, 2010
Ejaculatory status and fertility rates after primary retroperitoneal lymph node dissectionStephen D W Beck, Aaron L Bey, Richard Bihrle, et al.
Urology|March 27, 2007
Significance of primary tumor size and preorchiectomy serum tumor marker level in predicting pathologic stage at retroperitoneal lymph node dissection in clinical Stage A nonseminomatous germ cell tumorsStephen D W Beck, Richard S Foster, Richard Bihrle, et al.
The Journal of Urology|September 29, 2012
Clinical and pathological features predictive of nephrectomy at post-chemotherapy retroperitoneal lymph node dissectionK Clint Cary, Stephen D W Beck, Richard Bihrle, et al.
Journal of Pediatric Urology|August 27, 2010
Metastatic transitional cell carcinoma of the bladder arising in a patient with bladder autoaugmentationRahul Mehan, Rosalia Misseri, Brian Vanderbrink, et al.
The Journal of Urology|September 8, 2005
Does the histology of nodal metastasis predict systemic relapse after retroperitoneal lymph node dissection in pathological stage B1 germ cell tumors?Stephen D W Beck, Richard S Foster, Richard Bihrle, et al.
Urologic Oncology|September 9, 2010
Serum tumor markers in testicular cancerYaron Ehrlich, Stephen D W Beck, Richard S Foster, et al.
The Journal of Urology|February 14, 2007
Does the presence of extranodal extension in pathological stage B1 nonseminomatous germ cell tumor necessitate adjuvant chemotherapy?Stephen D W Beck, Liang Cheng, Richard Bihrle, et al.
The Journal of Urology|June 15, 2007
Short-term morbidity of primary retroperitoneal lymph node dissection in a contemporary group of patientsStephen D W Beck, Matthew D Peterson, Richard Bihrle, et al.
The Urologic Clinics of North America|May 9, 2007
Post chemotherapy RPLND in patients with elevated markers: current concepts and clinical outcomeStephen D W Beck, Richard S Foster, Richard Bihrle, et al.
Pageof 5